🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and arterial inflammation — my results so far Page 2

GLP-1 and arterial inflammation — my results so far

InsuranceTom Sat, Aug 17, 2024 at 10:26 AM 13 replies 1,976 viewsPage 2 of 3
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Aug 17, 2024 at 7:26 PM#6
TrialNerd_Beth said:
Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my…

I read this differently from TrialNerd_Beth, on substance rather than tone. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

Correct me if the detail matters more than I have assumed.

Last edited: Aug 17, 2024 at 8:26 PM
22 17SkepticalSean, Dr.CardioMD, EndoResFellow and 19 others
Reply Quote Save Share Report
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Aug 17, 2024 at 10:59 PM#7
InsuranceTom said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

21 16NicoleRaleigh, james_edin, FranDenver and 18 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Aug 18, 2024 at 2:32 AM#8
RetaRick_CA said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.
RetaRick_CA said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

Last edited: Aug 18, 2024 at 5:32 AM
20 15marcus_mpls, DeniseRN_TPA, SandraNC_45 and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Aug 18, 2024 at 6:05 AM#9

One thing that is still open after fiona_VT’s answer:

How long did you give it before you decided it was working?

19 14Admin, Dr.Martinez, mike_mod and 16 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Aug 18, 2024 at 11:08 PM#10
Dr.EndoIndy said:
RetaRick_CA said: ...we're creating a generation dependent on cardiovascular risk...

Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 → elevated homocysteine → increased cardiovascular risk marker.

The connection: B12 is a cofactor for homocysteine metabolism. Without adequate B12, homocysteine accumulates. This is ironic — taking a CV-protective medication while developing a CV risk factor from reduced nutrition.

Solution: comprehensive vitamin supplementation and regular lab monitoring. Don't let the medication's benefits be undermined by nutritional deficiencies.

39 12jim_asheville, matt_MKE, Dr.ReproEndo and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register